Vistagen Therapeutics, Inc. Common Stock
Market Cap
23M
Short interest (May 15)
4.5%
Net Short (Jun 03 ): 0.0%
Borrow Fee
1.26%
↑ 1.3%
Available Shares
2M
↓ 21.0%
Price Chart
Company Overview
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.